Free Trial
NASDAQ:VIVS

VivoSim Labs (VIVS) Stock Price, News & Analysis

$2.44 +0.57 (+30.48%)
As of 08/29/2025 04:00 PM Eastern

About VivoSim Labs Stock (NASDAQ:VIVS)

Key Stats

Today's Range
$1.83
$2.99
50-Day Range
$1.42
$2.44
52-Week Range
$1.41
$21.96
Volume
12.77 million shs
Average Volume
29,499 shs
Market Capitalization
$6.34 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive VIVS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for VivoSim Labs and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

VIVS Stock News Headlines

Elon’s Secret Social Security Bombshell
To All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social Security? What we just discovered in Washington will stun even the most seasoned insiders.tc pixel
See More Headlines

VIVS Stock Analysis - Frequently Asked Questions

VivoSim Labs' stock was trading at $1.91 at the beginning of 2025. Since then, VIVS stock has increased by 27.7% and is now trading at $2.44.

VivoSim Labs, Inc. (NASDAQ:VIVS) announced its quarterly earnings results on Tuesday, August, 12th. The company reported ($1.14) earnings per share (EPS) for the quarter. The company had revenue of $0.04 million for the quarter. VivoSim Labs had a negative net margin of 1,396.48% and a negative trailing twelve-month return on equity of 32.95%.

Shares of VIVS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Last Earnings
8/12/2025
Today
8/30/2025
Fiscal Year End
3/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:VIVS
CIK
1497253
Web
N/A
Fax
N/A
Employees
20
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($10.20)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$2.48 million
Net Margins
-1,396.48%
Pretax Margin
-1,399.30%
Return on Equity
-32.95%
Return on Assets
-21.31%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
4.52
Quick Ratio
4.52

Sales & Book Value

Annual Sales
$140 thousand
Price / Sales
45.31
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$3.67 per share
Price / Book
0.66

Miscellaneous

Outstanding Shares
2,600,000
Free Float
2,503,000
Market Cap
$6.34 million
Optionable
N/A
Beta
0.94
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for September 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report

This page (NASDAQ:VIVS) was last updated on 8/30/2025 by MarketBeat.com Staff
From Our Partners